Disappearance of slan-positive non-classical monocytes for diagnosis of chronic myelomonocytic leukemia with an associated inflammatory state
Authors:
- 14 August 2019
- journal article
- letter
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 105 (4) , e147-e152
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subsetNature Communications, 2018
- Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosisBlood Cancer Journal, 2018
- Clinical Utility of Classical and Nonclassical Monocyte Percentage in the Diagnosis of Chronic Myelomonocytic LeukemiaAmerican Journal of Clinical Pathology, 2018
- Flow cytometry based monocyte subset analysis accurately distinguishes chronic myelomonocytic leukemia from myeloproliferative neoplasms with associated monocytosisBlood Cancer Journal, 2017
- How I treat chronic myelomonocytic leukemiaBlood, 2017
- Monocyte subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosisBlood, 2017
- Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agentsNature Communications, 2016
- slan-defined subsets of CD16-positive monocytes: impact of granulomatous inflammation and M-CSF receptor mutationBlood, 2015
- Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemiaBlood, 2015
- The three human monocyte subsets: implications for health and diseaseImmunologic Research, 2012